Feldman v. Howmedica Osteonics Corporation

CourtDistrict Court, N.D. Texas
DecidedMay 15, 2020
Docket3:18-cv-01416
StatusUnknown

This text of Feldman v. Howmedica Osteonics Corporation (Feldman v. Howmedica Osteonics Corporation) is published on Counsel Stack Legal Research, covering District Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Feldman v. Howmedica Osteonics Corporation, (N.D. Tex. 2020).

Opinion

United States District Court NORTHERN DISTRICT OF TEXAS DALLAS DIVISION REBECCA FELDMAN § Vv. CIVIL ACTION NO. 3:18-CV-1416-S STRYKER CORPORATION et al. MEMORANDUM OPINION AND ORDER This Memorandum Opinion and Order addresses Defendant Howmedica Osteonics Corporation’s (“HOC”) Motion for Judgment on the Pleadings [ECF No. 60], Plaintiff Rebecca Feldman’s (“Plaintiff”) Motion for Leave to File an Amended Complaint [ECF No. 62], and HOC’s Motion for Sanctions [ECF No. 72]. For the following reasons, the Court GRANTS Plaintiffs Motion for Leave to File an Amended Complaint, FENDS AS MOOT HOC’s Motion for Judgment on the Pleadings, and DENIES HOC’s Motion for Sanctions. I. BACKGROUND This action arises out of an alleged defect in the bone cement manufactured, designed, licensed, distributed, sold, or marketed by HOC and OSARTIS GmbH f/k/a aap Biomaterials GmbH that was used in Plaintiffs total knee replacement surgery. See Compl. 2-7, 36-37; ECF No 62-1 (“Proposed Am. Compl.”) 99 2-5, 33-34. Since Plaintiff brought this action on June 1, 2018, the parties have stipulated to a protective order, see ECF No. 40, and have engaged in contentious discovery that included motions to compel, see ECF Nos. 44, 53. This case is currently set for jury trial on the Court’s three-week docket beginning June 7, 2021. See ECF No. 58 (“Am. Scheduling Order”), Pursuant to the parties’ original Scheduling Order, the deadline to amend pleadings passed on May 31, 2019. See ECF No. 34 (“Original Scheduling Order”) 9 3(b), This deadline was not extended by the parties’ amended Scheduling Order filed on November 4, 2019. See Am.

Scheduling Order 3(b). However, after HOC filed its Motion for Judgment on the Pleadings on January 2, 2020, Plaintiff filed her Motion for Leave to File an Amended Complaint. In response, HOC moved for Sanctions on April 1, 2020. All three motions are now ripe and before the Court. II. ANALYSIS A. Good Cause to Modify Scheduling Order As Plaintiff seeks to amend her Complaint after the May 31, 2019 deadline set forth by the Court’s Scheduling Order, see Original Scheduling Order 3(b); Am. Scheduling Order { 3(b), “the [C]ourt must first determine whether to modify the scheduling order under the good cause standard of” Federal Rule of Civil Procedure 16(b)(4).' Kouzbari v. Health Acquisition Co., Civ. A. No. 3:18-CV-0126-D, 2018 WL 6514766, at *1 (N.D. Tex. Dec. 11, 2018) (citations omitted), The Court assesses four factors in deciding whether to grant the motion: “(1) the explanation for the failure to timely move for leave to amend; (2) the importance of the amendment; (3) potential prejudice in allowing the amendment; and (4) the availability of a continuance to cure such prejudice.” Jd. at *2 (quoting S& W Enters, LLC. v. S. Tr. Bank of NA, 315 F.3d 533, 536 (Sth Cir. 2003)). “The Rule 16(b)(4) analysis is holistic,” such that the Court “does not mechanically count the number of factors that favor each side” but rather “focuses on the diligence of the party seeking to modify the scheduling order.” Jd. at *4 (quoting E.E.O.C. v. Serv. Temps, Inc., Civ. A. No. 3:08-CV-1552-D, 2009 WL 3294863, at *3 (N.D. Tex. Oct. 13, 2009), aff'd, 679 F.3d 323 (Sth Cir. 2012)). However, “[mJere inadvertence on the part of the movant is insufficient to constitute ‘good cause.’ Instead, the movant must show that,

' Although Plaintiff “does not address the good cause standard under Rule 16(b)(4)" in her Motion, the Court conducts the Rule 16(6)(4) analysis because the grounds for “good cause are relatively clear.” Miles v, Illini State Trucking Co., Civ. A. No. 3:16-CV-0778-D, 2017 WL 8677336, at *1 (N.D. Tex. May 4, 2017) (citation omitted).

despite its diligence, it could not have reasonably met the scheduling deadline.” Jd. (citation omitted), As to the first factor, the Court “remembers at all times that the good cause inquiry focuses on the diligence of the party seeking to modify the scheduling order.” Serv. Temps, Inc., 2009 WL 3294863, at *3. “When the court has denied a motion for leave to amend due to the movant’s lack of diligence, it has been because the movant possessed all necessary facts before the deadline and ‘otherwise [made] no showing of diligence that would excuse ignorance of facts’ in his possession.” Kouzbari, 2018 WL 6514766, at *2 (quoting Lopez v. Reliable Clean-Up & Support Servs., LLC, Civ. A. No. 3:16-CV-2595-D, 2018 WL 3609271, at *4 (N.D. Tex. July 27, 2018)). Here, Plaintiff secks to “add more detailed learned through initial discovery” that was obtained after the deadline to amend pleadings. See Br. in Supp. Mot. to Amend Compl. 3. In fact, Plaintiff explains that “[b]y the May 31st amendment deadline, [HOC] had produced 81 documents,” but that “[flour days after the Court entered the [amended] scheduling order” on November 4, 2019, HOC “supplemented its production to produce an additional 1,696 documents.” Reply in Supp. Mot. to Amend Compl. 5-6. Moreover, Plaintiff needed to “consult one of her experts” regarding the documents before seeking to amend her Complaint, see Br. in Supp. Mot. to Amend Compl. 3, and obtained an order compelling production of documents from HOC during the delay, see ECF Nos. 44, 53, 59, which “demonstrate[s] her diligence despite missing the scheduling order deadline,” Howard v. Medicredit, Inc., Civ. A. No, 3:17-CV-3224-D, 2018 WL 3752366, at *3 (N.D. Tex. Aug. 8, 2018). In view of HOC’s production of documents after the deadline for amending pleadings coupled with Plaintiff's diligence in prosecuting this action,” the Court finds that the first factor weighs in favor of granting Plaintiff's motion to amend.

* Although HOC faults Plaintiff for delaying her discovery, see Resp. in Opp. to Mot. to Amend Compl. 7, the record shows that Plaintiff served and received responses to her First Request for Production by May 6, 2019, see ECF

The Court further finds that the proposed amendment is important. Courts deem “amendments to be important where they ‘potentially provide[] additional grounds for [a party] to recover,’ or ‘directly affect[] [a party’s] prospects of ultimate recovery.’” Kouzbari, 2018 WL 6514766, at *3 (first and third alterations added) (first quoting Mid-Continent Cas. Co. v. Eland Energy, Inc., Civ, A. Nos. 3:06-CV-1576-D, 3:06-CV-1578-D, 2009 WL 3074618, at *37 (N.D. Tex. Mar. 30, 2009); and then quoting The Richards Grp., Inc. v. Brock, Civ. A. No. 3:06-CV- 0799-D, 2008 WL 1722250, at *2 (N.D. Tex. Apr. 14, 2008))}. In the present case, Plaintiff explains that her amendment is necessary to “cure... pleading defects HOC alleged for the following claims: manufacturing defect, marketing defect (failure to warn), breach of express warranty, and breach of implied warranty.” Br. in Supp. Mot. to Amend Compl. 4. This is sufficient to show the importance of the proposed amendment. See Maynard v. PayPal, Inc., Civ. A. No. 18-CV-0259-D, 2018 WL 5776268, at *4 (N.D. Tex. Nov. 2, 2018). As for the third and fourth factors, the Court finds that potential prejudice in allowing the amendment and the availability of a continuance in this case weigh in favor of granting leave to amend. See id. at *5. Although HOC argues that allowing the amendment would require it to reassert its dispositive motion or “reorient its strategy and conduct new discovery related to th[e] theory” raised in the amendment, see Resp. in Opp. to Mot. to Amend 9-10, the fact that HOC “would have to adjust [its] defense strategy to account for [Plaintiff's] new [allegations]...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Luis Tejero v. Portfolio Recovery Assoc, LL
955 F.3d 453 (Fifth Circuit, 2020)
Wimm v. Jack Eckerd Corp.
3 F.3d 137 (Fifth Circuit, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
Feldman v. Howmedica Osteonics Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/feldman-v-howmedica-osteonics-corporation-txnd-2020.